Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year follow-up of the GIMEMA CML 0307 study

We report the final analysis, with a 10-year follow-up, of the phase II study GIMEMA CML 0307 (NCT 00481052), which enrolled 73 adult patients (median age 51 years; range, 18-83) with newly diagnosed chronic-phase chronic myeloid leukemia to investigate the efficacy and the toxicity of front-line tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gugliotta, Gabriele, Castagnetti, Fausto, Breccia, Massimo, Levato, Luciano, Intermesoli, Tamara, D’Adda, Mariella, Salvucci, Marzia, Stagno, Fabio, Rege-Cambrin, Giovanna, Tiribelli, Mario, Martino, Bruno, Bocchia, Monica, Cedrone, Michele, Trabacchi, Elena, Cavazzini, Francesco, Porretto, Ferdinando, Sorà, Federica, Simula, Maria Pina, Albano, Francesco, Soverini, Simona, Foà, Robin, Pane, Fabrizio, Cavo, Michele, Saglio, Giuseppe, Baccarani, Michele, Rosti, Gianantonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Chronic Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521223/
https://www.ncbi.nlm.nih.gov/pubmed/35385922
http://dx.doi.org/10.3324/haematol.2021.280175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521223/
https://www.ncbi.nlm.nih.gov/pubmed/35385922
http://dx.doi.org/10.3324/haematol.2021.280175

Ejemplares similares